Business
Shilpa Medicare and Gate2brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy
Barcelona [Spain] / Raichur (Karnataka) [India], June 8: Shilpa Biocare Pvt Ltd, a subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company…
More from Business
Middle East conflict, fuel price surge to halve global airline profits in 2026: IATA
Global airline industry profits are expected to halve in 2026 as the conflict in the Middle East and a sharp rise in…
India needs faster energy reforms, tough decisions to reduce dependence on imported fuel: Neelkanth Mishra
India needs to move faster on energy reforms and take tougher policy decisions if it wants to reduce its dependence on imported…
Centrum sees RBI extending rate pause till October despite inflation risks
The Reserve Bank of India (RBI) is unlikely to raise interest rates in its August monetary policy review and may keep them…
India can win in AI deployment despite lagging in advanced chips: Neelkanth Mishra
India may be behind the global leaders in artificial intelligence and semiconductor manufacturing, but the country has a significant opportunity to create…
Rupee volatility is “liquidity problem, not solvency”, fix needs $70-100 billion capital visibility: Neelkanth Mishra
Mishra emphasised that while the exact exchange rate level (such as crossing the 100-mark) is largely psychological, the volatility itself inflicts real…
Private investment jumps to Rs 56 lakh crore in FY26, signalling capex momentum: SBI Research
Private investment announcements rose sharply to Rs 56 lakh crore in FY26 from Rs 37 lakh crore in the previous year, indicating…